B-type natriuretic peptide measurement for early diagnosis of acute pulmonary edema during pregnancy

1Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Calcium-channel blockers administered to pregnant women as tocolytic agents can cause acute pulmonary edema. The first signs of this severe complication can be atypical and so delay introduction of appropriate therapy. We describe three cases in whom B-type natriuretic peptide measurements proved to be relevant in early diagnosis and monitoring of pregnant women with acute pulmonary edema. B-type natriuretic peptide measurement in this setting could contribute to timely diagnosis and improve follow-up.

Cite

CITATION STYLE

APA

Seror, J., Lefevre, G., Berkane, N., Richard, F., Bornes, M., Uzan, S., & Berkane, N. (2014). B-type natriuretic peptide measurement for early diagnosis of acute pulmonary edema during pregnancy. Acta Obstetricia et Gynecologica Scandinavica, 93(12), 1317–1319. https://doi.org/10.1111/aogs.12472

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free